Novel Anticancer Agents: Strategies for Discovery and Clinical Testing

Alex A. Adjei, John K. Buolamwini

Research output: Book/ReportBook

Abstract

Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents. At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.

Original languageEnglish (US)
PublisherElsevier
Number of pages437
ISBN (Electronic)9780120885619
DOIs
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Medicine

Fingerprint

Dive into the research topics of 'Novel Anticancer Agents: Strategies for Discovery and Clinical Testing'. Together they form a unique fingerprint.

Cite this